Form 4: Amgen Director Charles M. Holley Reports Acquisition of Common Stock

Director Charles M. Holley reports acquiring Amgen common stock through restricted stock units and dividend equivalents.

Summary

• Charles M. Holley, a director at Amgen Inc., filed a Form 4 on May 7, 2024, reporting a transaction involving Amgen's common stock.
• Holley acquired 141.5251 shares of common stock at a price of $0.
• These shares were obtained through restricted stock units (RSUs) granted under the Amgen Inc. 2009 Director Incentive Program, which vested immediately.
• The report also indicates that Holley indirectly owns 1,260 shares through the Holley Family Trust.
• The reported holdings include 912 Dividend Equivalents (DEs) granted pursuant to the Director Program.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, indicating standard compensation practices.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.
• The immediate vesting of RSUs suggests a straightforward compensation structure for directors.

Future Outlook

The document does not contain specific forward-looking statements, but it implies continued participation in the Amgen Inc. 2009 Director Incentive Program.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in the pharmaceutical industry where equity-based compensation is prevalent.

Comparison to Industry Standards

• Equity compensation for board members is a common practice across the pharmaceutical industry.
• Companies like Johnson & Johnson, Pfizer, and Merck also utilize stock options and restricted stock units as part of their director compensation packages.
• The specific terms of Amgen's Director Incentive Program, such as vesting schedules and dividend equivalent policies, would need to be compared to those of its peers to assess its competitiveness.

Stakeholder Impact

• The acquisition of shares by a director could have a minor positive impact on shareholder sentiment, reflecting confidence in the company.

Key Dates